Department of Medicine
-
December 4, 2025
Vanderbilt-Ingram researchers present cancer advancements at ASH 2025
Established in 1958, ASH is the world’s largest professional organization for clinicians and scientists who study blood diseases. -
December 3, 2025
Large-scale integration of genomics, proteomics and clinical records identifies cancer risk proteins and potential therapeutics
A new study identifies previously unreported protein biomarkers and candidate drug targets across six major cancer types and highlights approved drugs with potential cancer preventive effects. -
December 2, 2025
Ketamine fails surgical recovery trial
In a large, placebo-controlled, randomized trial, the pain reliever ketamine posed side effects while failing to aid patient recovery after major surgery. -
December 1, 2025
Timothy Sterling receives $5.7 million to study tuberculosis transmission
Using molecular and other data from both the bacterial and human sides of the equation, a multi-institutional team will develop prediction models of TB transmission. -
November 26, 2025
Protein plays dual roles in repairing damaged kidney
These findings were unexpected and demonstrate that the actin cytoskeleton repairs cell organelles like mitochondria in a regulated way. -
November 14, 2025
Andrew DeFilippis named director of VUMC’s Division of Cardiovascular Medicine
He serves as associate chief of staff at Vanderbilt University Hospital and served as the medical director of the Cardiovascular Intensive Care Unit from 2020 to 2025. -
November 13, 2025
Vanderbilt Institute for Global Health marks 20 years
Since its founding in 2005, VIGH has grown from a small team focused on HIV/AIDS research to an institute with projects in more than 20 countries and more than 150 faculty members and staff.